Rachner, Tilman D.
Göbel, Andy http://orcid.org/0000-0003-0918-4064
Hoffmann, Oliver
Erdmann, Kati
Kasimir-Bauer, Sabine
Breining, Dorit
Kimmig, Rainer
Hofbauer, Lorenz C.
Bittner, Ann-Kathrin
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (GO 3055/1-1, RA 2151/2-1, RA 2151/4-1)
Deutsche Krebshilfe (70113573)
Article History
Received: 8 January 2020
Accepted: 3 February 2020
First Online: 10 February 2020
Compliance with ethical standards
:
: SKB is a consultant for QIAGEN, Hilden, Germany. The authors have received honoraria, unrestricted educational grants and research funding from to the individual or the institution by Alexion (LCH), Amgen (LCH, TDR), Roche (TDR), Shire (LCH, TDR), and UCB (LCH, TDR). All other authors declare no potential conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Samples of patients were obtained before therapy after written informed consent from all subjects using protocols approved by the clinical ethic committee of the University Hospital Essen (05/2856).